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Introduction greater saphenous vein, placed along the same route.
The seroma did not recur and the fistula remained
A perigraft seroma is a collection of clear and sterile patent on the last follow up at 4 months.
ultrafiltered serum, encased by a fibrous pseudo-
capsule, that develops around a patent prosthetic vas-
Case 2cular graft. Several treatments have been suggested
but none have proved to be consistently satisfactory.
A 50-year-old man, under haemodyalisis for 20 years,We describe four cases of perigraft seroma com-
had his long-standing left brachioaxillary 6-mm dia-plicating brachioaxillary arteriovenous polytetra-
meter PTFE arteriovenous bridge fistula abandonedfluoroethylene bridge fistula. Extensive dissection,
because it thrombosed repeatedly. A new left bra-heparin and corticoid therapies were predisposing
chioaxillary PTFE arteriovenous bridge fistula wasfactors. All cases were managed successfully by re-
constructed along a new subcutaneous route. Theplacing the transuding segment of prosthesis with
arterial anastomosis was constructed to a 1 cm-longautogenous vein and excision of the pseudo-capsule.
segment of the old, well-incorporated prosthesis, ana-This procedure resulted in resolution of the seroma
stomosed to the brachial artery. The venous ana-with preservation of the arteriovenous graft, leaving
stomosis was constructed to the more proximal axillarythe shunt immediately available for cannulation of the
vein. A perigraft seroma ensued around the arterialunreplaced segment.
anastomosis. Twelve weeks later the seroma and its
pseudocapsule were resected. During surgery, it was
observed that the old retained segment of prosthesis
Case 1 was encased in fibrous tissue while the new prosthesis
was transuding. The 4-cm long, transuding proximal
A 59-year-old man with end-stage renal failure under- segment of prosthesis at the arterial anastomosis was
went a left brachioaxillary arteriovenous 6-mm dia- replaced with reversed greater saphenous vein, which
meter polytetrafluoroethylene (PTFE) bridge fistula was interposed between the old, well-incorporated 1-
because of a lack of suitable veins. A perigraft seroma cm long segment and the remaining new PTFE pros-
developed around the arterial anastomosis. Three thesis. The seroma did not recur and the vascular
weeks later aspiration was attempted without success. access remained patent on last follow up at 4 months.
The culture of the fluid was negative. Two weeks
afterwards the pseudocapsule was resected. The 4-cm
long, transuding proximal segment of prosthesis at Case 3
the arterial anastomosis was replaced with reversed
A 59-year-old woman on haemodialysis for 3 years,
developed a pseudoaneurysm at a repeatedly punc-∗ Please address all correspondence to: Gonc¸alo Sobrinho, Rua
Toma´s da Anunciac¸a˜o 169 1 D, 1350-326 Lisboa, Portugal. tured site in the middle of an well-incorporated left
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brachioaxillary 6-mm diameter PTFE arteriovenous glucocorticoids may have impaired the incorporation
of the graft and promoted the formation of seroma.bridge fistula. The pseudoaneurysm was resected and
replaced with a 4-cm long PTFE interposition through Both these patients had PTFE arteriovenous bridge
fistulæ in the past that were not complicated withthe same tunnel, because a new route would not
be compatible with the short length of the resected seroma. No predisposing factors could be identified
in Cases 1 and 2.segment. A perigraft seroma ensued around the in-
terposition. Therefore, 12 days later, the seroma and Several techniques for the correction of this com-
plication have been described in small series or isolatedits pseudocapsule were resected and the PTFE in-
terposition was replaced with a 4-cm long segment of case reports:
reversed greater saphenous vein. The seroma did not (1) aspiration with or without removal of the pseudo-
recur and the vascular access remained patent at one- capsule;2
month follow-up. The patient subsequently died of an (2) reconstruction through a new route with an ident-
unrelated complication. ical or different prosthetic material;2
(3) replacement with umbilical vein2 or homograft
iliac artery;3
(4) topical application of microfibrillar collagen4 orCase 4
Histoacryl tissue adhesive;5
(5) wrapping with collagen fleece soaked in fibrinA 40-year-old woman on haemodialysis patient for 5
years, was taking 60 mg of prednisolone per day for glue6 or absorbable collagen haemostat;7
(6) intraluminal injection of fibrin glue;8systemic lupus erythematosus. Her previous arterio-
venous left brachioaxillary 6-mm diameter PTFE (7) plasmapheresis.9
bridge fistula thrombosed repeatedly and had to be In the present report we describe a successful cor-
replaced by an identical ipsilateral haemodialysis ac- rective procedure with autogenous vein interposition
cess through a new route, with new vascular-prosthesis in four cases of perigraft seroma complicating bra-
anastomoses. After surgery, she was put on continuous chioaxillary standard PTFE (manufactured by Gore-
heparin infusion, 20 000 units daily to prevent the Tex) arteriovenous bridge fistula. Culture of the fluid
thrombosis of the access. This was discontinued the collected at surgery was negative in all cases. Mac-
following day because of haemorrhage. roscopic examination of the resected PTFE showed the
A perigraft seroma ensued around the arterial ana- outer surface transuding fine drops of clear fluid, not
stomosis. Interposing a new prosthetic graft through covered with fibrous tissue. The lumen was widely
a new tunnel was not possible because the seroma patent. Histological examination was not performed.
was large and dissected the tissues around. Seven The seroma and its pseudocapsule were resected.
weeks later a procedure identical to the one used in Then, the transuding proximal segment of prosthesis
Case 1 was done. The obtained fluid was sterile. The at the arterial anastomosis was replaced with reversed
seroma did not recur. The vascular access thrombosed greater saphenous vein, placed along the same route.
10 months later but thrombectomy was performed A 1-mm cuff of prosthesis was left anastomosed to
successfully with a Fogarty catheter. the artery. This made suturing easier and reduced the
likelihood of arterial stenosis. The removal of the
pseudocapsule does cause bleeding. A closed suction
drain was left for 1–2 days. The pseudocapsule wasDiscussion
removed because this has been reported to be more
effective than simple drainage (72% vs 53%) when thePerigraft seromas have been reported both with Da-
cron and PTFE prostheses. In arteriovenous bridge graft is not replaced.2 It has also been postulated that
the removal of the fibroblasts of the pseudocapsulefistulae, seromas appear as painless lumps around the
arterial anastomosis. Although most seromas remain allows new fibroblasts, not influenced by a fibroblast
inhibitor, to incorporate the graft more effectively.10stable and complication-free for long periods of time,
0.5 % to 2.5 % of all patients with prosthetic grafts The greater saphenous vein was harvested from
the thigh. The saphenofemoral junction should berequire treatment.1 Predisposing factors for this com-
plication have been postulated. In case 3 seroma de- preserved so it can remain available for an eventual
arteriovenous femorosaphenous vascular access.veloped after placing the prosthesis through an
extensively dissected route. Heparin, used in our case The venous graft can be placed along an extensively
dissected route, prone to seroma and infection when4, impairs the deposition of fibrin and may be as-
sociated with perigraft seroma.1 Also, in this case, prosthesis is used. As only part of the shunt is replaced,
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